Unite Genomics

Name: Unite Genomics
Brand: Unite Genomics

Unify data. Access Insights. Elevate Health

Est 2015|Valuation $9.5M|Raised $7.8M|2 Ref Customers

LinkedIn 651|Web traffic 6K|FTEs 10|HQ San Mateo, California, US

01Competitive Landscape

Shortlist for comparison

Comparisons focus on positioning and available public information rather than direct price parity due to the lack of public pricing for Unite.

Top competitors considered:

PicnicHealth (patient-mediated records with curated longitudinal timelines)
Flatiron Health (oncology-focused RWD and evidence generation)
Seqster (patient record aggregation and interoperability)

Narrative analysis

- Areas where Unite may offer advantage - If coverage and access-speed claims are realized in practice, the platform could enable faster patient record access relative to heavily manual retrieval approaches. - The combination of record retrieval, NLP extraction, and patient engagement features indicates an intent to provide both data and operational workflows. - Areas where alternatives may outperform - Flatiron: deep, oncology-focused datasets and a strong evidence-generation and publication record. - PicnicHealth: transparent participant-oriented operations and publicly available pricing/participant policies in some offerings. - Claims-first analytics vendors (for example, Komodo): may offer larger scale in certain analytic use cases where granular chart detail is less critical. - Customer choice signals (limited public evidence) - Public testimonials and partner references suggest a fit for rare disease and research collaborations, but public buyer comparisons and independent performance data are limited.

	Unite Genomics	PicnicHealth	Flatiron Health
Starting Price	Not public (demo-based)	Participant model: free for research participants; consumer subscription noted in public sources	Not public (enterprise); product implementations typically involve onboarding and subscription fees
Typical Use Case	Biopharma, advocacy programs using patient-mediated EHR access combined with NLP and engagement workflows (vendor positioning)	Studies needing curated longitudinal records from consented patients; consumer and research models exist	Oncology RWD / RWE, deep clinical curation and publication ecosystem
Key Strength (publicly stated)	Vendor-claimed broad coverage and fast access; combined data + engagement positioning	Clear patient-centric operational model and publicly visible participant pricing/support resources	Strong oncology-specific dataset credibility, publication track record, and regulatory collaborations
Key Weakness (publicly visible)	Limited quantified case studies publicly available; security/certification details not posted	May be less focused on genomic offerings or automated extraction at scale	Domain specialization in oncology may not suit non-oncology rare disease programs

01Competitive Landscape

Shortlist for comparison

Comparisons focus on positioning and available public information rather than direct price parity due to the lack of public pricing for Unite.

Top competitors considered:

PicnicHealth (patient-mediated records with curated longitudinal timelines)
Flatiron Health (oncology-focused RWD and evidence generation)
Seqster (patient record aggregation and interoperability)

Narrative analysis

Areas where Unite may offer advantage
- If coverage and access-speed claims are realized in practice, the platform could enable faster patient record access relative to heavily manual retrieval approaches.
- The combination of record retrieval, NLP extraction, and patient engagement features indicates an intent to provide both data and operational workflows.
Areas where alternatives may outperform
- Flatiron: deep, oncology-focused datasets and a strong evidence-generation and publication record.
- PicnicHealth: transparent participant-oriented operations and publicly available pricing/participant policies in some offerings.
- Claims-first analytics vendors (for example, Komodo): may offer larger scale in certain analytic use cases where granular chart detail is less critical.
Customer choice signals (limited public evidence)
- Public testimonials and partner references suggest a fit for rare disease and research collaborations, but public buyer comparisons and independent performance data are limited.

	Unite Genomics	PicnicHealth	Flatiron Health
Starting Price	Not public (demo-based)	Participant model: free for research participants; consumer subscription noted in public sources	Not public (enterprise); product implementations typically involve onboarding and subscription fees
Typical Use Case	Biopharma, advocacy programs using patient-mediated EHR access combined with NLP and engagement workflows (vendor positioning)	Studies needing curated longitudinal records from consented patients; consumer and research models exist	Oncology RWD / RWE, deep clinical curation and publication ecosystem
Key Strength (publicly stated)	Vendor-claimed broad coverage and fast access; combined data + engagement positioning	Clear patient-centric operational model and publicly visible participant pricing/support resources	Strong oncology-specific dataset credibility, publication track record, and regulatory collaborations
Key Weakness (publicly visible)	Limited quantified case studies publicly available; security/certification details not posted	May be less focused on genomic offerings or automated extraction at scale	Domain specialization in oncology may not suit non-oncology rare disease programs

Unite Genomics

01Competitive Landscape

Shortlist for comparison

Narrative analysis

02Market Map

01Competitive Landscape

Shortlist for comparison

Narrative analysis

02Market Map